NCT05009810

Efficacy and Safety of Astaxanthin in Volunteer With Refraction Errors

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Chulalongkorn University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking astaxanthin for 1 and 2 months.

Detailed description

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. They will divided into 3 groups which are astaxanthin 4 mg group , astaxanthin 6 mg group, and placebo group. They will take the sample 1 capsule once daily for 2 months. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking the sample for 1 and 2 months.

Conditions

• Refractive Errors

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	astaxanthin 4 mg	They will take astaxanthin 4 mg 1 capsule once daily for 2 months.
DIETARY_SUPPLEMENT	astaxanthin 6 mg	They will take astaxanthin 6 mg 1 capsule once daily for 2 months.
DIETARY_SUPPLEMENT	Placebo	They will take placebo 1 capsule once daily for 2 months.

Timeline

• Start date: 2021-08-15
• Primary completion: 2022-06-30
• Completion: 2022-07-31
• First posted: 2021-08-18
• Last updated: 2021-08-18